Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Inspire Medical Systems (INSP) Income from Continuing Operations (2017 - 2025)

Inspire Medical Systems' Income from Continuing Operations history spans 9 years, with the latest figure at 136090000.0 for Q4 2025.

  • For Q4 2025, Income from Continuing Operations rose 286.71% year-over-year to 136090000.0; the TTM value through Dec 2025 reached 145422000.0, up 171.79%, while the annual FY2025 figure was 145422000.0, 171.77% up from the prior year.
  • Income from Continuing Operations for Q4 2025 was 136090000.0 at Inspire Medical Systems, up from 9905000.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 136090000.0 in Q4 2025 and bottomed at 16847000.0 in Q3 2022.
  • The 5-year median for Income from Continuing Operations is 6051000.0 (2023), against an average of 4544700.0.
  • The largest annual shift saw Income from Continuing Operations skyrocketed 369.62% in 2023 before it plummeted 136.07% in 2025.
  • A 5-year view of Income from Continuing Operations shows it stood at 2391000.0 in 2021, then skyrocketed by 231.74% to 3150000.0 in 2022, then surged by 369.62% to 14793000.0 in 2023, then surged by 137.9% to 35192000.0 in 2024, then skyrocketed by 286.71% to 136090000.0 in 2025.
  • Per Business Quant, the three most recent readings for INSP's Income from Continuing Operations are 136090000.0 (Q4 2025), 9905000.0 (Q3 2025), and 3532000.0 (Q2 2025).